Um alle Funktionen dieser Seite zu nutzen, aktivieren Sie bitte die Cookies in Ihrem Browser.
my.bionity.com
Mit einem my.bionity.com-Account haben Sie immer alles im Überblick - und können sich Ihre eigene Website und Ihren individuellen Newsletter konfigurieren.
- Meine Merkliste
- Meine gespeicherte Suche
- Meine gespeicherten Themen
- Meine Newsletter
Switzerland ENT Devices Investment Opportunities, Analysis and Forecasts to 2017
Introduction
“Switzerland ENT Devices Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Switzerland ENT Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within five market categories – Hearing Aid Devices, Hearing Implants, Diagnostic Devices, Voice Prosthesis, and Nasal Splints. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for ENT Devices market categories – Hearing Aid Devices, Hearing Implants, Diagnostic Devices, Voice Prosthesis, and Nasal Splints.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within five market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the five market categories.
- Global corporate-level profiles of key companies operating within the Switzerland ENT Devices market.
- Key players covered include Sonova Holding AG, William Demant Holding A/S, Widex A/S, Siemens Healthcare, GN ReSound A/S, Cochlear Limited and others.
Highlights
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Switzerland ENT Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Report Highlights
Sonova Holding AG
William Demant Holding A/S
Widex A/S
Siemens Healthcare
GN ReSound A/S
Cochlear Limited
Starkey Laboratories, Inc.
Sonic Innovations, Inc.
MED-EL
Welch Allyn Inc.
Atos Medical AB
| Gesundheitspflege / Medizinprodukte | Marktstudie | |
|---|---|---|
| Jahrgang: | 2011 | |
| Preis: | 2,500.00 |
Marktstudie bestellen
Bestellen Sie die Marktstudie bei markt-studie.de
Merkliste
Hier setzen Sie die nebenstehende Marktstudie auf Ihre persönliche Merkliste.
